Activity

Mobile apps are suggested for supporting home monitoring and reducing emergency department (ED) visits and hospitalizations for children with medical complexity (CMC). None have been implemented. We sought to assess the MyChildCMC app (1) feasibility for CMC home monitoring, (2) ability to detect early deteriorations before ED and hospital admissions, and (3) preliminary impact.

Parents of CMC (aged 1-21 years) admitted to a children’s hospital were randomly assigned to MyChildCMC or usual care. MyChildCMC subjects recorded their child’s vital signs and symptoms daily for 3 months postdischarge and received real-time feedback. Feasibility measures included parent’s enrollment, retention, and engagement. The preliminary impact was determined by using quality of life, parent satisfaction with care, and subsequent ED and hospital admissions and hospital days.

A total of 62 parents and CMC were invited to participate 50 enrolled (80.6% enrollment rate) and were randomly assigned to MyChildCMC (

= 24) or ulth for timely interventions that might avoid ED and hospitalizations. A larger and definitive study of MyChildCMC’s impact and sustainability is needed.

Pancreatic ductal adenocarcinoma (PDAC) shows a remarkable predilection for liver metastasis. Pro-oncogenic secretome delivery and trafficking via exosomes are crucial for pre-metastatic microenvironment formation and metastasis. This study aimed to explore the underlying mechanisms of how PDAC-derived exosomes (Pex) modulate the liver microenvironment and promote metastasis.

C57BL/6 mice were ‘educated’ by tail vein Pex injection. The intrasplenic injection liver metastasis and PDAC orthotopic transplantation models were used to evaluate liver metastasis. Stable cell lines CD44v6 (CD44 variant isoform 6) or C1QBP (complement C1q binding protein) knockdown or overexpression was established using lentivirus transfection or gateway systems. A total of 142 patients with PDAC in Huashan Hospital were retrospectively enrolled. Prognosis and liver metastasis were predicted using Kaplan-Meier survival curves and logistic regression models.

Pex tail vein injection induced the deposition of liver fibrotic extracssed exosomal CD44v6 and C1QBP are promising biomarkers for predicting prognosis and liver metastasis in patients with PDAC.

Current guidelines recommending rapid revascularisation of symptomatic carotid stenosis are largely based on data from clinical trials performed at a time when best medical therapy was potentially less effective than today. The risk of stroke and its predictors among patients with symptomatic carotid stenosis awaiting revascularisation in recent randomised controlled trials (RCTs) and in medical arms of earlier RCTs was assessed.

The pooled data of individual patients with symptomatic carotid stenosis randomised to stenting (CAS) or endarterectomy (CEA) in four recent RCTs, and of patients randomised to medical therapy in three earlier RCTs comparing CEA vs. medical therapy, were compared. The primary outcome event was any stroke occurring between randomisation and treatment by CAS or CEA, or within 120 days after randomisation.

A total of 4 754 patients from recent trials and 1 227 from earlier trials were included. In recent trials, patients were randomised a median of 18 (IQR 7, 50) days after the qutment is advisable.

Patients with symptomatic carotid stenosis enrolled in recent large RCTs had a lower risk of stroke after randomisation than historical controls. The added benefit of carotid revascularisation to modern medical care needs to be revisited in future studies. Until then, adhering to current recommendations for early revascularisation of patients with symptomatic carotid stenosis considered to require invasive treatment is advisable.

To assess the efficacy of butorphanol-azaperone-medetomidine (BAM) and butorphanol-midazolam-medetomidine (BMM) protocols for immobilization of wild common palm civets (Paradoxurus musangus) with subsequent antagonization with atipamezole.

Prospective, randomized, blinded clinical trial.

A total of 40 adult wild common palm civets, 24 female and 16 male, weighing 1.5-3.4 kg.

The civets were randomly assigned for anesthesia with butorphanol, azaperone and medetomidine (0.6, 0.6 and 0.2 mg kg

, respectively; group BAM) or with butorphanol, midazolam and medetomidine (0.3, 0.4 and 0.1 mg kg

, respectively; group BMM) intramuscularly (IM) in a squeeze cage. When adequately relaxed, the trachea was intubated for oxygen administration. Physiological variables were recorded every 5 minutes after intubation. Following morphometric measurements, sampling, microchipping and parasite treatment, medetomidine was reversed with atipamezole at 1.0 or 0.5 mg kg

IM to groups BAM and BMM, respectively. Physiologicats. The BMM combination had the advantage of producing complete relaxation that allowed intubation more rapidly.Sustainable biorefinery concepts based on lignocellulosic biomass are gaining worldwide research interest because of their inexpensiveness and abundance. The recalcitrance of lignocellulosic biomass poses a major hindrance to enhance biofuel production. Therefore, a pretreatment step is critical to prepare the substrates for the downstream process. Combining pretreatment steps help to lower the severity of the drawbacks of a single pretreatment step. This paper systematically reviews the combined biological and chemical/physicochemical pretreatment based on fiber degradation and sugar yield. An energy-efficient biological pretreatment method combined with a chemical pretreatment that accelerates the pretreatment times has been seen to be efficient for fiber degradation and sugar yields. However, fungal species, culture conditions, biomass type, the severity of chemical pretreatment and the order of sequential pretreatment influences the relative component contents and sugar yield. Even the same biomass from different sources undergoing similar pretreatment conditions could result in a varying amount of digestibility.

Hypospadias is a congenital birth defect affecting around one in every 300 male infants, characterized by incomplete fusion of the urethralfold.Our objective was to identify drug and chemical exposure in pregnancy associated with increased risk for hypospadias.

We conducted a scoping review of studies of drugs and chemicals associated with hypospadias by searching Medline, EMBASE, Cochrane, Google and Google Scholar from inception to October 9, 2020 in any language. We searched for the terms; drugs, medications, chemicals, environmental agents, hypospadias, humans, In these papers we evaluated the existence of statistical evidence for an association between exposure to drugs and chemicals, and the occurrence of hypospadias. In examining the statistical evidence, we noted whether an association was made between a drug or chemical and hypospadias at p<0.05, or Odds Ratio or Relative risk above 1, where the lower 95% confidence interval is also above 1. We also noted whether the study’s statistical method adjusted for co-variates or confounders.

Significant statistical evidence for association between hypospadias and the following drugs and chemicals has been verified Progestins, dydrogesterone, clomiphene, ibuprofen, venlafaxine, endocrine disruptors, valproic acid and polybrominated diphenyl esters flame retardants.

There is increasing accumulation and quality of evidence of drugs and chemicals associated with hypospadias in humans. These may partially explain the rise in the prevalence of male reproductive health disorders in the last fifty years. Advising women of reproductive age about these risks should be an important component of prenatal counseling.

There is increasing accumulation and quality of evidence of drugs and chemicals associated with hypospadias in humans. These may partially explain the rise in the prevalence of male reproductive health disorders in the last fifty years. Advising women of reproductive age about these risks should be an important component of prenatal counseling.

Early orchidopexy has been linked to improved long term outcomes of fertility and reduced malignancy rates. However, the optimal age of intervention has been subject to change over the years.

This study aims to study males aged 6 months or less who undergo laparoscopic assisted orchidopexy for intraabdominal testes to establish the safety, efficacy, and benefit in the defined age group.

We prospectively assessed 19 boys at or below 6 months of age, who had laparoscopic assisted orchidopexy for intraabdominal undescended testes at Salmaniya Medical Complex in Bahrain between January 2014 and December 2018. We examined demographics, laterality, testicular locations, testicular volumes, operative time, complications, and durations of hospitalization and follow-up. Ultrasound-derived testicular volumes were assessed before and after orchidopexy. They were calculated using the Hansen formula (Testicular volume=0.52×length [L]×width [W]

[1]. selleck products They were then compared with reference ranges from a Dutch cohort associated intra-abdominal testes with greater risks of complications, we found few minor complications and no testicular atrophy [3,4]. Testicular volumes in the affected testes were normal, contrary to decreased volumes found by other researchers [5]. Limitations of this study are the small number of patients and short follow-up which limits assessment of long-term outcomes.

Early orchiopexy is safe and effective. Laparoscopic assisted orchidopexy at an early age was beneficial and resulted in normal testicular volumes before and after surgery.

Early orchiopexy is safe and effective. Laparoscopic assisted orchidopexy at an early age was beneficial and resulted in normal testicular volumes before and after surgery.

Amongst critically ill trauma patients admitted to ICU and still alive and in ICU after 24 hours, it is unclear which trauma scoring system offers the best performance in predicting in-hospital mortality.

The Australia and New Zealand Intensive Care Society Adult Patient Database and Victorian State Trauma Registry were linked using a unique patient identification number. Six scoring systems were evaluated the Australian and New Zealand Risk of Death (ANZROD), Acute Physiology and Chronic Health Evaluation III (APACHE III) score and associated APACHE III Risk of Death (ROD), Trauma and Injury Severity Score (TRISS), Injury Severity Score (ISS), New Injury Severity Score (NISS) and the Revised Trauma Score (RTS). Patients who were admitted to ICU for longer than 24 hours were analysed. Performance of each scoring system was assessed primarily by examining the area under the receiver operating characteristic curve (AUROC) and in addition using standardised mortality ratios, Brier score and Hosmer-Lemeshow C when compared with traditional trauma-specific scoring systems in predicting hospital mortality. This was observed both overall and in each of the subgroup analyses. The anatomical scoring systems all performed poorly in the ICU population of Victoria, Australia.

In ICU patients admitted with a trauma diagnosis and still alive and in ICU after 24 hours, ANZROD and APACHE III had a superior performance when compared with traditional trauma-specific scoring systems in predicting hospital mortality. This was observed both overall and in each of the subgroup analyses. The anatomical scoring systems all performed poorly in the ICU population of Victoria, Australia.